Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
1.480
+0.080 (5.71%)
Nov 16, 2026, 12:36 PM EST - Market open
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $15.09 million as of November 16, 2026. It is the 39,087th most valuable company in the world and the 5,340th biggest in the United States. Its market cap has decreased by 89.99% in one year.
Market Cap
15.09M
Enterprise Value
33.33M
1-Year Change
-89.99%
Global Rank
Country Rank
#5,340 United States
Category
ChartMarket Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $15.09M, a decrease of -99.20%. That is a compound annual growth rate of -34.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 15.09M | -88.79% |
| Dec 31, 2025 | 134.60M | -5.14% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
| Jun 26, 2015 | 1.88B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 16.46M |
| Acumen Pharmaceuticals | 15.85M |
| Jasper Therapeutics | 15.69M |
| NewcelX | 15.65M |
| Akari Therapeutics, | 14.92M |
| Pasithea Therapeutics | 14.91M |
| Actuate Therapeutics | 14.85M |
| Marker Therapeutics | 14.70M |